Planet 13 Revenue Drops 14% in Q2

Planet 13 (PLNH) reported a challenging Q2 2025, with GAAP revenue declining 13.6% year-over-year to $26.9 million, missing estimates, and Adjusted EBITDA swinging to a $2.4 million loss from a $3.2 million profit. The cannabis retailer's GAAP net loss widened significantly to $13.3 million and cash holdings decreased, driven by industry-wide price compression, increased competition, and softer consumer demand. Management is focusing on core Florida and Nevada markets and reviewing other assets, but cost-cutting efforts have yet to offset sales declines, raising investor concerns about profitability and liquidity given the absence of explicit forward guidance.

Analysis

Planet 13's Q2 2025 results reveal a significant deterioration in financial performance and operational health, driven by severe external pressures. GAAP revenue fell 13.6% year-over-year to $26.9 million, missing consensus estimates, while the GAAP net loss widened by 64.8% to $13.3 million. The core issue is a collapse in profitability, evidenced by the gross margin contracting from 50.9% to 43.4% and, more critically, Adjusted EBITDA swinging from a $3.2 million profit in the prior year to a $2.4 million loss. Management attributes these declines to industry-wide price compression, increased competition from both legal and illicit markets, and weaker consumer demand, particularly in its key Nevada market. While the company is implementing cost-cutting measures, a 4.6% reduction in total expenses was insufficient to offset the revenue slide. The balance sheet is also showing signs of stress, with cash holdings decreasing by nearly a third to $15.9 million in the first six months of 2025, indicating a substantial cash burn rate. Strategically, the company is refocusing on its Florida and Nevada operations and has put its Illinois and California assets under review, signaling potential divestitures. However, the lack of explicit forward guidance, coupled with a recent CFO transition, creates significant near-term uncertainty and undermines management's previous target of achieving positive operating cash flow.

Key Decisions for Investors

• Investors should critically assess the company's liquidity runway, as the significant cash burn of $7.5 million in six months against a $15.9 million cash balance may necessitate dilutive financing if operating losses continue.
• Absent formal guidance, focus on non-financial KPIs, such as gross margin trends and the sales velocity of the new Florida dispensaries, as primary indicators of whether the company's restructuring and strategic refocus are gaining traction.
• The severe erosion in fundamentals and lack of a clear timeline for recovery warrant a re-evaluation of the investment thesis, as the stock will likely face continued pressure until there is tangible evidence that profitability can be restored.
• Monitor for announcements regarding the strategic review of the Illinois and California assets, as any potential divestiture could provide a near-term cash infusion but would also alter the company's long-term geographic footprint and growth profile.